178 related articles for article (PubMed ID: 36099465)
1. Molecular genetic tests GeneXpert MTB/RIF and Xpert MTB/RIF (Ultra) in the diagnosis of tuberculosis (review of literature).
Borodulina EA; Piskun VV; Uraksina MV; Shubina AT
Klin Lab Diagn; 2022 Sep; 67(9):544-549. PubMed ID: 36099465
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of extrapulmonary tuberculosis by GeneXpert MTB/RIF Ultra assay.
Dahiya B; Mehta N; Soni A; Mehta PK
Expert Rev Mol Diagn; 2023; 23(7):561-582. PubMed ID: 37318829
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of GeneXpert
Habous M; E Elimam MA; Kumar R; L Deesi ZA
Int J Mycobacteriol; 2019; 8(2):132-137. PubMed ID: 31210154
[TBL] [Abstract][Full Text] [Related]
4. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
5. The New Xpert MTB/RIF Ultra: Improving Detection of
Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D
mBio; 2017 Aug; 8(4):. PubMed ID: 28851844
[TBL] [Abstract][Full Text] [Related]
6. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
[TBL] [Abstract][Full Text] [Related]
7. Xpert
Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis.
Mechal Y; Benaissa E; El Mrimar N; Benlahlou Y; Bssaibis F; Zegmout A; Chadli M; Malik YS; Touil N; Abid A; Maleb A; Elouennass M
BMC Infect Dis; 2019 Dec; 19(1):1069. PubMed ID: 31856744
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis in an intermediate-prevalence setting].
Ozkutuk N; Surucüoglu S
Mikrobiyol Bul; 2014 Apr; 48(2):223-32. PubMed ID: 24819260
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the diagnostic performance of Xpert MTB/RIF test for the detection of Mycobacterium tuberculosis and rifampin resistance in clinical samples].
Gürsoy NC; Yakupoğulları Y; Tekerekoğlu MS; Otlu B
Mikrobiyol Bul; 2016 Apr; 50(2):196-204. PubMed ID: 27175492
[TBL] [Abstract][Full Text] [Related]
11. Performance Comparison of GeneXpert MTB/RIF, Gene Chip Technology, and Modified Roche Culture Method in Detecting
Xie C; Hu X; Liu Y; Shu C
Contrast Media Mol Imaging; 2022; 2022():2995464. PubMed ID: 35935306
[TBL] [Abstract][Full Text] [Related]
12. Frequency of rifampicin-resistant mycobacterium tuberculosis by GeneXpert MTB/RIF assay and its correlates among 2605 probable tuberculosis patients in upper Egypt.
Hassanin ESA; Mohamed Hussein AA; Abdelrheem SS; Dongol E; Mhsb AHA; Zahran AM; Zein M; G Sayed I
Indian J Tuberc; 2023 Jul; 70(3):345-355. PubMed ID: 37562911
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the GeneXpert MTB/RIF assay on extrapulmonary and respiratory samples other than sputum: a low burden country experience.
Pandey S; Congdon J; McInnes B; Pop A; Coulter C
Pathology; 2017 Jan; 49(1):70-74. PubMed ID: 27913043
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of molecular detection of extrapulmonary tuberculosis and resistance to rifampicin with GeneXpert® MTB/RIF.
Marouane C; Smaoui S; Kammoun S; Slim L; Messadi-Akrout F
Med Mal Infect; 2016 Feb; 46(1):20-4. PubMed ID: 26654321
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
17. GeneXpert
Christopher PM; ; Widysanto A
Int J Mycobacteriol; 2019; 8(4):351-358. PubMed ID: 31793505
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of the new Xpert MTB/RIF Ultra for tuberculosis disease: A preliminary systematic review and meta-analysis.
Zhang M; Xue M; He JQ
Int J Infect Dis; 2020 Jan; 90():35-45. PubMed ID: 31546008
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of Xpert MTB/RIF results for the detection of Mycobacterium tuberculosis in clinical samples].
Ciftçi IH; Aslan MH; Aşık G
Mikrobiyol Bul; 2011 Jan; 45(1):43-7. PubMed ID: 21341158
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
Mavenyengwa RT; Shaduka E; Maposa I
Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
